Member Info for Livedataaccount

Is there more to come or is that the pipeline revealed?

#letsdothis

Very, very, very, very, very good partnership!

Thanks, Hurst.

A sensible post at last.

In TNBC, 52.5% of patients have high expression of FAP. High expression of FAP is also associated with recurrence

FAP is a potential target for diagnosis and treatment of tumors. Approaches to targeting FAP include antibodies, vaccines, immunoconjugates, CAR T cells, peptide drug complexes, and FAP inhibitors (FAPI).

That's an excellent write up. Thanks for sharing

Anyone else having trouble opening?

They seem to be including breast cancer in phase 1b. A shift away from solely soft tissue sarcoma as per previous updates.

Surely this is big news!

#peptidescreatehope

I told you days ago it's breast cancer they are after! Come in guys, keep up.

Size trades

Good news!

#peptidescreatehope

Oops, I mean 7100

Is this one going to be the warhead for breast cancer?

And the Americans are just waking up now!

It would nice to get an American based cfo.

Perhaps ex glaxo or pfizer

The current cfos tenure ends at the end of the month. So not long to find out.

Americans online early?

Thanks for all the answers

This has been quite an interesting thread.

My conclusion is ava6000 has proved pre cision works. Another 10 warheads have been tested and it's a case of come on big pharma come get on bard with these potent killer warheads

Can someone who knows what they are talking about tell me. Does this mean 10 separate pre clinical studies? 10 seperate entries in the pipeline?

Avacta King of Conjugates

#KOC